Treating cancer with immunotherapies known as an immune checkpoint blockade (ICB) prior to surgery (so-called neoadjuvant immunotherapy) has been a rapidly growing area of research, but the scientific community is just scratching ...
Sep 28, 2023
0
20
It's no secret that our lungs play a vital role in our daily lives—ensuring we can breathe, fend off infections, and adapt to various challenges. Despite their importance, the organs still puzzle many medical experts, especially ...
Sep 26, 2023
0
29
Lung fibrosis is a debilitating disease affecting nearly 250,000 people in the U.S. alone with 50,000 new cases reported each year. There is currently no cure and limited available treatment options, underscoring the pressing ...
Sep 26, 2023
0
52
A third of people hospitalized with COVID-19 have "abnormalities" in multiple organs months after getting infected, a UK study said on Saturday, potentially shedding light on the elusive condition of long COVID.
Sep 23, 2023
0
106
A combination immunotherapy treatment of nivolumab plus ipilimumab was associated with no improvement in survival for advanced cancers other than melanoma, when compared to nivolumab alone, according to a recent Northwestern ...
Sep 22, 2023
0
59
Lung cancer is the leading cause of cancer-related deaths in the United States. Some tumors are extremely small and hide deep within lung tissue, making it difficult for surgeons to reach them. To address this challenge, ...
Sep 21, 2023
0
31
Smart users of social media protect themselves by deleting suspicious "friend requests" that might serve as a gateway to harmful content. Similarly, our immune system uses its own judgment to identify cellular "profiles" ...
Sep 20, 2023
0
26
While immunotherapies have shown great promise in treating blood cancers, most clinical trials aimed at treating solid tumors such as pancreatic or lung cancer have failed. Researchers have long thought that solid tumors' ...
Sep 18, 2023
0
138
Combination immunotherapy with the anti-PD-L1 monoclonal antibody durvalumab and other novel agents outperforms durvalumab alone in the neoadjuvant (pre-surgical) setting for early-stage non-small-cell lung cancer (NSCLC), ...
Sep 14, 2023
0
66
New research published today in Nature Genetics describes the largest-ever study into the genetics of random "round-the-clock" blood glucose levels. The study, involving almost half a million people of diverse backgrounds, ...
Sep 7, 2023
0
99
